COLES N ANTHONY
SEC CIK 1197018 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals | Dir | 1,714 | — | $20.62M | 15 | 2021-08-13 | 2026-01-02 |
Most active insiders at REGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | POON CHRISTINE A | Dir | — | $4.25M |
| 2 | McCourt Marion | EVP Commercial | — | $2.00M |
| 3 | Zoghbi Huda Y | Dir | — | $1.92M |
| 4 | Pitofsky Jason | VP Ctrl | — | $1.87M |
| 5 | Bassler Bonnie L | Dir | — | $1.77M |
| 6 | Guarini Kathryn | Dir | — | $660.0K |
| 7 | RYAN ARTHUR F | Dir | — | $434.7K |
| 8 | MURPHY ANDREW J | EVP Research | — | — |
| 9 | Fenimore Christopher R. | EVP Fin CFO | — | — |
| 10 | Schenkein David P | Dir | — | — |
| 18 | COLES N ANTHONY | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | A - Grant | $0.00 | +155 | 1,714 | +10% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | A - Grant | $0.00 | +166 | 1,559 | +12% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | A - Grant | $0.00 | +135 | 1,393 | +11% | $0 |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | A - Grant | $0.00 | +165 | 1,258 | +15% | $0 |
| DM | 2022-12-30 | 2022-12-28 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | S - Sale+OE | $714.11 | -5,758 | 1,404 | -80% | -$4.11M |
| DM | 2022-12-30 | 2022-12-28 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | M - OptEx | $442.24 | +5,758 | 6,851 | +527% | +$2.55M |
| DM | 2022-09-08 | 2022-09-06 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | S - Sale+OE | $581.28 | -6,000 | 5,470 | -52% | -$3.49M |
| DM | 2022-09-08 | 2022-09-06 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | M - OptEx | $372.40 | +6,000 | 6,793 | +757% | +$2.23M |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | A - Grant | $0.00 | +191 | 1,093 | +21% | $0 |
| DM | 2021-09-17 | 2021-09-15 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | M - OptEx | $365.99 | +11.9K | 12.8K | +1,325% | +$4.37M |
| DM | 2021-09-17 | 2021-09-15 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | S - Sale+OE | $658.98 | -11.9K | 2,981 | -80% | -$7.87M |
| DM | 2021-08-19 | 2021-08-17+ | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | M - OptEx | $345.47 | +6,000 | 1,802 | New | +$2.07M |
| DM | 2021-08-19 | 2021-08-17+ | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | S - Sale+OE | $650.00 | -6,000 | 902 | -87% | -$3.90M |
| D | 2021-08-16 | 2021-08-13 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | S - Sale+OE | $625.00 | -2,000 | 902 | -69% | -$1.25M |
| D | 2021-08-16 | 2021-08-13 | REGN | Regeneron Pharmaceuticals | COLES N ANTHONY | Dir | M - OptEx | $345.47 | +2,000 | 2,902 | +222% | +$690.9K |
Purchase Sale Sale after option exercise All abbreviations